You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A randomized, multicenter, open-label, active-controlled, single-dose, 5-period, incomplete block, cross-over study to evaluate the relative bronchodilating effects of formoterol when administered via Symbicort pMDI or Oxis Turbuhaler to adults with stable asthma.
- Disease
- asthma
- Drug Name
- Symbicort
- Generic Name
- budesonide/formoterol
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- II
- Start Date
- Oct 16, 2002
- Study Name
- SD-039-0729
- Study Id
- SD-039-0729
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
